The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index.
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Open accessAbstract
In the last two decades, considerable interest has been shown in understanding the development of the gut microbiota and its internal and external effects on the intestine, as well as the risk factors for cardiovascular diseases (CVDs) such as metabolic syndrome. The intestinal microbiota plays a pivotal role in human health and disease. Recent studies revealed that the gut microbiota can affect the host body. CVDs are a leading cause of morbidity and mortality, and patients favor death over chronic kidney disease. For the function of gut microbiota in the host, molecules have to penetrate the intestinal epithelium or the surface cells of the host. Gut microbiota can utilize trimethylamine, N-oxide, short-chain fatty acids, and primary and secondary bile acid pathways. By affecting these living cells, the gut microbiota can cause heart failure, atherosclerosis, hypertension, myocardial fibrosis, myocardial infarction, and coronary artery disease. Previous studies of the gut microbiota and its relation to stroke pathogenesis and its consequences can provide new therapeutic prospects. This review highlights the interplay between the microbiota and its metabolites and addresses related interventions for the treatment of CVDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–284 of 284
Lin, C., Liu, H., Pan, C., Chuang, C., Jayakumar, T., Wang, T.-J., Chen, H., & Wu, C. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.08.002 · Cited by 156
Stepankova, R., Tonar, Z., Bartova, J., Nedorost, L., Rossman, P., Poledne, R., Schwarzer, M., & Tlaskalova-Hogenova, H. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3285 · Cited by 155 · cited 1×
“A summary of therapeutic approaches that can be employed to alleviate CVD is shown in the schematic diagram (Figure 3; Stepankova et al., 2010).”
BackgroundRandomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients
Ranganathan, N., Pechenyak, B., Vyas, U. N., Ranganathan, P., Weinberg, A. D., Liang, P., Mallappallil, M. C., Norin, A. J., Friedman, E. A., & Saggi, S. J. (2014) · BioMed Research International · doi:10.1155/2014/568571 · Cited by 153
Hedin, C. R. H., McCarthy, N. E., Louis, P., Farquharson, F. M., McCartney, S. A., Taylor, K. M., Prescott, N. J., Murrells, T., Stagg, A. J., Whelan, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306226 · Cited by 153
Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction
Suzuki, T., Heaney, L. M., Jones, D. J. L., & Ng, L. L. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.264853 · Cited by 152
Iron Modulates Butyrate Production by a Child Gut Microbiota In Vitro
Dostal, A., Lacroix, C., Bircher, L., Pham, V. T., Follador, R., Zimmermann, M. B., & Chassard, C. (2015) · mBio · doi:10.1128/mbio.01453-15 · Cited by 151
Implication of Gut Microbiota in Cardiovascular Diseases
Zhou, W., Cheng, Y., Zhu, P., Nasser, M. I., Zhang, X., & Zhao, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5394096 · Cited by 149
Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing
Cui, L., Zhao, T., Hu, H., Zhang, W., & Hua, X. (2017) · BioMed Research International · doi:10.1155/2017/3796359 · Cited by 145
Simenhoff, M. L., Dunn, S., Zollner, G. P., Fitzpatrick, M. E., Emery, S. M., Sandine, W. E., & Ayres, J. W. (1996) · PubMed · Cited by 143
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Rahman, M. M., Islam, M. R., Shohag, S., Ahasan, M. T., Sarkar, N., Khan, H., Hasan, A. M., Cavalu, S. D., & Rauf, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112898 · Cited by 142
Self-citationEvans, C. E. L., Greenwood, D. C., Threapleton, D. E., Cleghorn, C. L., Nykjaer, C., Woodhead, C. E., Gale, C. P., & Burley, V. J. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000515 · Cited by 140
Oral microbiota in patients with atherosclerosis
Fåk, F., Tremaroli, V., Bergström, G. M. L., & Bäckhed, F. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.097 · Cited by 137
The Role of the Gut Microbiome on Chronic Kidney Disease
Sampaio‐Maia, B., Simões‐Silva, L., Pestana, M., Araújo, R., & Soares‐Silva, I. (2016) · Advances in applied microbiology · doi:10.1016/bs.aambs.2016.06.002 · Cited by 134
The Influence of CKD on Colonic Microbial Metabolism
Poesen, R., Windey, K., Neven, E., Kuypers, D. R. J., Preter, V. D., Augustijns, P., D’Haese, P. C., Evenepoel, P., Verbeke, K., & Meijers, B. K. I. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030279 · Cited by 133
The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure?
Khodor, S. A., Reichert, B., & Shatat, I. F. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00138 · Cited by 131
Chambers, E. S., Byrne, C., Aspey, K., Chen, Y., Khan, S., Morrison, D. J., & Frost, G. S. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13159 · Cited by 128
Karlsson, C., Ahrné, S., Molin, G., Berggren, A., Palmquist, I., Fredrikson, G. N., & Jeppsson, B. W. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.019 · Cited by 126
Xu, D., He, G., Mai, K., Zhou, H., Xu, W., & Song, F. B. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515004535 · Cited by 126
Association of Indoxyl Sulfate with Heart Failure among Patients on Hemodialysis
Cao, X., Chen, J., Zou, J., Zhong, Y., Teng, J., Ji, J., Chen, Z., Liu, Z., Shen, B., Nie, Y., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04730514 · Cited by 122
Yoo, H. H., Kim, I. S., Yoo, D.-H., & Kim, D. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000773 · Cited by 120
Rahman, M. M., Rahaman, M. S., Islam, M. R., Hossain, M. E., Mithi, F. M., Ahmed, M., Saldías, M., Akkol, E. K., & Sobarzo‐Sánchez, E. (2021) · Antibiotics · doi:10.3390/antibiotics10091076 · Cited by 112
Self-citationDivyashri, G., Krishna, G., ., M., & Prapulla, S. G. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000184 · Cited by 110
The evolving epidemiology of inflammatory bowel disease
Shanahan, F., & Bernstein, C. N. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32832b12ef · Cited by 109
Low Fibre Intake is Associated with Gut Microbiota Alterations in Chronic Heart Failure
Mayerhofer, C. C. K., Kummen, M., Holm, K., Broch, K., Awoyemi, A., Vestad, B., Storm-Larsen, C., Seljeflot, I., Ueland, T., Bohov, P., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12596 · Cited by 107
Shafi, T., Meyer, T. W., Hostetter, T. H., Melamed, M. L., Parekh, R. S., Hwang, S., Banerjee, T., Coresh, J., & Powe, N. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126048 · Cited by 99
A cross-talk between gut microbiome, salt and hypertension
Naqvi, S., Asar, T. O., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., Kamal, M. A., & Anwar, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111156 · Cited by 99
Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences
Serino, M., Blasco-Baque, V., Nicolas, S., & Burcelin, R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0540-1 · Cited by 93
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives
Rahman, M. M., Islam, M. R., Islam, M. T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., Uddin, M., Das, S. K., Rahaman, M. S., Ahmed, M., et al. (2022) · Biology · doi:10.3390/biology11010147 · Cited by 93
Self-citationCanfora, E. E., & Blaak, E. E. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000408 · Cited by 91
Disparate effects of antibiotics on hypertension
Galla, S., Chakraborty, S., Cheng, X., Yeo, J., Mell, B., Zhang, H. Y., Mathew, A. V., Vijay–Kumar, M., & Joe, B. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00073.2018 · Cited by 91
Cardos, I. A., Zaha, D. C., Sindhu, R. K., & Cavalu, S. D. (2021) · Molecules · doi:10.3390/molecules26196078 · Cited by 90
Self-citationBeyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes
Nielsen, D. S., Krych, Ł., Buschard, K., Hansen, C. H. F., & Hansen, A. K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.010 · Cited by 86
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Sharma, A., Buschmann, M. M., & Gilbert, J. A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1437 · Cited by 86
The microbiota and chronic kidney diseases: a double‐edged sword
Felizardo, R. J. F., Castoldi, A., Andrade‐Oliveira, V., & Câmara, N. O. S. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.36 · Cited by 85
Gut Microbiota and Cardiovascular Uremic Toxicities
Velasquez, M. T., Centron, P., Barrows, I. R., Dwivedi, R. S., & Raj, D. S. (2018) · Toxins · doi:10.3390/toxins10070287 · Cited by 85
Wong, J. M. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.071639 · Cited by 84
Rahman, M. M., Islam, F., Parvez, A., Azad, A., Ashraf, G. M., Ullah, M. F., & Ahmed, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2101042 · Cited by 84
Self-citationAssociations of Indigenous Microorganisms with Gastrointestinal Mucosal Epithelia
Savage, D. C. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.11.1495 · Cited by 83
Li, Q., Wu, T., Liu, R., Zhang, M., & Wang, R. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700473 · Cited by 83
Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease
Kikuchi, M., Ueno, M., Itoh, Y., Suda, W., & Hattori, M. (2017) · Nephron · doi:10.1159/000450619 · Cited by 82
Hyvärinen, K., Mäntylä, P., Buhlin, K., Paju, S., Nieminen, M. S., Sinisalo, J. P., & Pussinen, P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.021 · Cited by 81
THE POSSIBLE INVOLVEMENT OF INTESTINAL BACTERIA IN STEROIDAL HYPERTENSION
HONOUR, J. (1982) · Endocrinology · doi:10.1210/endo-110-1-285 · Cited by 80
Chen, L., Aris, I. M., Bernard, J. Y., Tint, M. T., Chia, A., Colega, M., Gluckman, P. D., Shek, L. P., Saw, S., Chong, Y. S., et al. (2016) · Nutrients · doi:10.3390/nu9010002 · Cited by 80
Orekhov, A. N., Poznyak, A. V., Sobenin, I. A., Nikifirov, N. N., & Ivanova, E. A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191118125018 · Cited by 80
Qi, Y., Aranda, J. M., Rodriguez, V., Raizada, M. K., & Pepine, C. J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.07.078 · Cited by 79 · cited 1×
“However, now, a few studies have revealed a visible relationship between high BP and the gut microbiota in animals (Mell et al., 2015; Qi et al., 2015; Yang et al., 2015; Adnan et al., 2017).”
BackgroundDevillard, E., McIntosh, F. M., Paillard, D., Thomas, N. A., Shingfield, K. J., & Wallace, R. J. (2009) · Microbiology · doi:10.1099/mic.0.023416-0 · Cited by 79
Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola, C., Rocchetti, M. T., Sabatino, A., Fiaccadori, E., Iorio, B. R. D., & Gesualdo, L. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0516-0 · Cited by 79
Islam, F., Mitra, S., Nafady, M. H., Rahman, M. T., Tirth, V., Akter, A., Emran, T. B., Mohamed, A. A.-R., Algahtani, A., & El-Kholy, S. S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6144733 · Cited by 77
Self-citationMediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients
Mekki, K., Bouzidi-bekada, N., Kaddous, A., & Bouchenak, M. (2010) · Food & Function · doi:10.1039/c0fo00032a · Cited by 76
Fu, Q., Zhao, M., Wang, D., Hu, H., Guo, C., Chen, W., Li, Q., Zheng, L., & Chen, B. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.071 · Cited by 76
Butyrate ameliorated-NLRC3 protects the intestinal barrier in a GPR43-dependent manner
Cheng, D., Xu, J., Li, J., Wang, S., Wu, T., Chen, Q., & Yu, T. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.04.018 · Cited by 72
From obesity through gut microbiota to cardiovascular diseases: a dangerous journey
Marzullo, P., Renzo, L. D., Pugliese, G., Siena, M. D., Barrea, L., Muscogiuri, G., Colao, A., & Savastano, S. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0017-1 · Cited by 71
Gut microbiota in chronic kidney disease
Cigarrán, S., Parra, E. G., & Cases, A. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.01.017 · Cited by 71
Foye, O. T., Huang, I., Chiou, C. C., Walker, W. A., & Shi, H. N. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00978.x · Cited by 70
Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile.
Feitoza, A. B., Pereira, A. F., da Costa, N. F., & Ribeiro, B. G. (2009) · PubMed · Cited by 69
The gut‐kidney axis in chronic renal failure: A new potential target for therapy
Khoury, T., Tzukert, K., Abel, R., Rmeileh, A. A., Levi, R., & Ilan, Y. (2016) · Hemodialysis International · doi:10.1111/hdi.12486 · Cited by 69
Shimazu, S., Hirashiki, A., Okumura, T., Yamada, T., Okamoto, R., Shinoda, N., Takeshita, K., Kondo, T., Niwa, T., & Murohara, T. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0715 · Cited by 66
Diet alters probiotic L actobacillus persistence and function in the intestine
Tachon, S., Lee, B., & Marco, M. L. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12297 · Cited by 65
Nazzal, L., Roberts, J., Singh, P., Jhawar, S. R., Matalon, A., Gao, Z., Holzman, R. S., Liebes, L., Blaser, M. J., & Lowenstein, J. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx029 · Cited by 64
Gut hormones and gut microbiota: implications for kidney function and hypertension
Afsar, B., Vaziri, N. D., Aslan, G., Tarim, K., & Kanbay, M. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.10.007 · Cited by 63
Prevalence of Unhealthy Lifestyle Patterns Among Overweight and Obese Adults
Kushner, R. F., & Choi, S. (2009) · Obesity · doi:10.1038/oby.2009.376 · Cited by 63
Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis
Chaves, L. D., McSkimming, D. I., Bryniarski, M. A., Honan, A. M., Abyad, S., Thomas, S. A., Wells, S., Buck, M. J., Sun, Y., Genco, R. J., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2018 · Cited by 62
Melamed, M. L., Plantinga, L., Shafi, T., Parekh, R. S., Meyer, T. W., Hostetter, T. H., Coresh, J., & Powe, N. R. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-134 · Cited by 60
Gut microbiome as a novel cardiovascular therapeutic target
Singh, V., Yeoh, B. S., & Vijay–Kumar, M. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.01.002 · Cited by 60
Rune, I., Rolin, B., Larsen, C. S., Nielsen, D. S., Kanter, J. E., Bornfeldt, K., Lykkesfeldt, J., Buschard, K., Kirk, R. K., Christoffersen, B. Ø., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146439 · Cited by 57
Sato, B., Yoshikawa, D., Ishii, H., Suzuki, S., Inoue, Y., Takeshita, K., Tanaka, M., Kumagai, S., Matsumoto, M., Okumura, S., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.11.025 · Cited by 56
Microbiome and hypertension: where are we now?
Vallianou, N. G., Geladari, E. V., & Kounatidis, D. C. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000900 · Cited by 56
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Islam, F., Bibi, S., Meem, A. F. K., Islam, M. M., Rahaman, M. S., Bepary, S., Rahman, M. M., Rahman, M. M., Elzaki, A. A., Kajoak, S. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312638 · Cited by 56
Self-citationMetagenomic heterogeneity explains dual immune effects of endotoxins
Brix, S., Eriksen, C., Larsen, J. M., & Bisgaard, H. F. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.036 · Cited by 52
Lemos, B. S., Vera, I., Malysheva, O., Caudill, M. A., & Fernández, M. L. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1466213 · Cited by 50
Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases
Sindhu, R. K., Goyal, A., Yapar, E. A., & Cavalu, S. D. (2021) · Applied Sciences · doi:10.3390/app112211031 · Cited by 47
Self-citationENALAPRILAT IMPROVES GUT PERFUSION IN CRITICALLY INJURED PATIENTS
Kincaid, E. H., Miller, P. R., Meredith, J. W., & Chang, M. (1998) · Shock · doi:10.1097/00024382-199802000-00001 · Cited by 42
Effects of a novel propionate-rich sourdough bread on appetite and food intake
Darzi, J., Frost, G. S., & Robertson, M. D. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.1 · Cited by 42
Cavalu, S. D., Bisboaca, S., Mateș, I. M., Pasca, P. M., Laslo, V., Costea, T. O., Fritea, L., & Vicaş, S. I. (2019) · Revista de Chimie · doi:10.37358/rc.18.12.6836 · Cited by 41
Self-citationEmerging Promise of Nanoparticle-Based Treatment for Parkinson’s disease
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac106.71357151 · Cited by 41
Huang, X., Li, Z., Zhu, L., Huang, H., Hou, L., & Lin, J. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000369 · Cited by 37
The influence of gut microbiota in cardiovascular diseases—a brief review
Almeida, C., Barata, P., & Fernandes, R. (2021) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000106 · Cited by 36
Adamberg, K., Kolk, K. W. V. D., Jaagura, M., Vilu, R., & Adamberg, S. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0198 · Cited by 35
The effects of fasting on drug metabolism
Lammers, L. A., Achterbergh, R., Mathôt, R. A. A., & Romijn, J. A. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1706728 · Cited by 32 · cited 1×
“Individual therapeutic responses and drug-related side effects differ based on various factors such as gender, age, BMI, disease state, environmental factors, and genetic polymorphisms (Lammers et al., 2020).”
BackgroundMicroscopic and spectroscopic investigation of bioactive glasses for antibiotic controlled release
Cavalu, S. D., Bănică, F., Gruian, C., Vanea, E., Göller, G., & Simon, V. (2013) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2013.02.016 · Cited by 31
Self-citationAwoyemi, A., Trøseid, M., Arnesen, H., Solheim, S., & Seljeflot, I. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.05.004 · Cited by 31
Rahman, M. M., Ferdous, K. S., Ahmed, M., Islam, M. T., Khan, M. R., Perveen, A., Ashraf, G. M., & Uddin, M. S. (2021) · Current Gene Therapy · doi:10.2174/1566523221666210303100805 · Cited by 30
Self-citationGut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer
Wu, W., Ivanova, E. A., & Orekhov, A. N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.017 · Cited by 29
Bugs and Drugs: Insights into the Pathogenesis of Inflammatory Bowel Disease
Nguyen, G. C. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.308 · Cited by 23
Cited by
Lagoumintzis, G., & Patrinos, G. P. (2023) · Human Genomics · doi:10.1186/s40246-023-00561-w · Cited by 132
The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders
Młynarska, E., Barszcz, E., Budny, E., Gajewska, A., Kopeć, K., Wasiak, J., Rysz, J., & Franczyk, B. (2025) · Nutrients · doi:10.3390/nu17071135 · Cited by 44
Inflammation: Is It a Healer, Confounder, or a Promoter of Cardiometabolic Risks?
Tate, A. R., & Rao, G. H. R. (2024) · Biomolecules · doi:10.3390/biom14080948 · Cited by 42
Khanmohammadi, S., Fallahtafti, P., Habibzadeh, A., Ezzatollahi Tanha, A., Alamdari, A. A., Fallahtafti, P., & Shafi Kuchay, M. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02544-3 · Cited by 19
“For instance, dysbiosis can lead to increased intestinal permeability, allowing endotoxins such as lipo-polysaccharides to enter the bloodstream and trigger inflammatory responses that exacerbate hepatic steatosis and fibrosis [36].”
Metadata
- Authors
- Rahman, M. M., Islam, F., -Or-Rashid, M. H., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., Emran, T. B., Fatimawali, Idroes, R., Tallei, T. E., Ahmed, M., & Cavalu, S.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-20
- Volume
- 12
- Pages
- 903570-903570
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W4283170263
- Cited by
- 253
- References
- 284
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.